NCT02713269 2026-04-17
Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
Clinical Trials
38 trialsNCT05119296 2026-04-17
Phase II Trial of Pembrolizumab in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer
Stanford University
Phase 2 Active not recruiting
NCT01709292 2026-04-16
Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT03624751 2026-04-15
Follow up for Patients With Thyroid Cancer Planed for Radioiodine Scan or Treatment
Taichung Veterans General Hospital
Active not recruiting
NCT04061980 2026-04-13
Encorafenib and Binimetinib With or Without Nivolumab in Treating Patients With Metastatic Radioiodine Refractory BRAF V600 Mutant Thyroid Cancer
Providence Health & Services
Phase 2 Active not recruiting
NCT04948437 2026-04-13
Urinary Exosomal Biomarkers of Thyroglobulin and Galectin-3 for Prognosis and Follow-up in Patients of Thyroid Cancer
National Taiwan University Hospital
Active not recruiting
NCT05463107 2026-04-13
Correlation Between Various Urinary Exosomal Protein Biomarkers and Pathological Manifestation in Thyroid Follicular Neoplasm: Early and Pre-operative Diagnosis of Follicular Thyroid Cancer
National Taiwan University Hospital
Active not recruiting
NCT07255482 2026-03-24
Mortality Benefit of Ultrasound for Thyroid Nodules Identified With PET Imaging: Non-Inferiority Emulated Target Trial
Brigham and Women's Hospital
Active not recruiting
NCT03360890 2026-03-13
iPRIME
University of Chicago
Phase 2 Active not recruiting
NCT03570021 2026-03-06
ESTIMABL3
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3 Active not recruiting
NCT07434206 2026-02-25
Safety and Efficacy of Dexmedetomidine in Controlling Hemodynamics During Resection of Active Thyroid Secreting Tumors
South Egypt Cancer Institute
Phase 2/3 Active not recruiting
NCT04171622 2026-02-17
Lenvatinib and Pembrolizumab for the Treatment of Stage IVB Locally Advanced and Unresectable or Stage IVC Metastatic Anaplastic Thyroid Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT04459273 2026-02-05
FAPI PET RDRC
Jonsson Comprehensive Cancer Center
Phase 1 Active not recruiting
NCT04495985 2026-01-28
CASE 1320: RAI Uptake and Serum Prolactin in Thyroid Cancer
The Cleveland Clinic
Active not recruiting
NCT03181100 2026-01-09
Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT03484884 2026-01-07
A Study of Optical Imaging With Light From Radiotracers in Cancer Patients
Memorial Sloan Kettering Cancer Center
Active not recruiting
NCT07296575 2025-12-22
Ultrasound Large-scale Model in Thyroid Field: A Multi-center Study on Medical-Engineering Integration
Second Affiliated Hospital of Nanchang University
Active not recruiting
NCT04624477 2025-11-28
Active Surveillance and Surgery Outcomes in Low Risk Papillary Thyroid Cancer
University Health Network, Toronto
Active not recruiting
NCT03271892 2025-11-26
AS-PTC
University Health Network, Toronto
Active not recruiting
NCT04759911 2025-11-13
Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT01552434 2025-10-14
Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
NCT04623801 2025-10-08
Laser Ablation of Papillary Thyroid Microcarcinoma
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT04544111 2025-10-07
PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT04285476 2025-09-23
PREDICYTHY
Institut du Cancer de Montpellier - Val d'Aurelle
Phase NA Active not recruiting
NCT02657551 2025-09-11
A Study Using Regorafenib as Second or Third Line Therapy in Metastatic Medullary Thyroid Cancer
Dana-Farber Cancer Institute
Phase 2 Active not recruiting
NCT07124065 2025-08-15
Differentiation of Benign From Malignant Thyroid Nodules Using Diffuse Reflectance Spectroscopy
Imperial College London
Active not recruiting
NCT01412762 2025-08-03
Measuring Patient Expectations for Thyroid Surgery
Memorial Sloan Kettering Cancer Center
Active not recruiting
NCT01141309 2025-07-22
Evaluating the Combination of Everolimus and Sorafenib in the Treatment of Thyroid Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT03215095 2025-07-17
RAI Plus Immunotherapy for Recurrent/Metastatic Thyroid Cancers
Memorial Sloan Kettering Cancer Center
Phase EARLY_PHASE1 Active not recruiting
NCT04238624 2025-07-02
Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT04000880 2025-06-12
AMPLIFY
University of Alabama at Birmingham
Phase NA Active not recruiting
NCT03196518 2025-06-05
Study of PET Imaging With 18F-TFB in Patients With Thyroid Cancer
Memorial Sloan Kettering Cancer Center
Phase NA Active not recruiting
NCT04522570 2025-04-30
Thermal Ablation of Cervical Metastases From Thyroid Carcinoma
Instituto do Cancer do Estado de São Paulo
Phase NA Active not recruiting
NCT05541380 2025-04-20
A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Advanced Thyroid Cancer Patients (TOPICS-THYROID)
National Health Research Institutes, Taiwan
Active not recruiting
NCT04802876 2025-03-21
ACROPOLI
SOLTI Breast Cancer Research Group
Phase 2 Active not recruiting
NCT05377736 2025-01-06
Thyroid Nodule Gene Sequencing in a Danish Population
University of Aarhus
Phase NA Active not recruiting
NCT01398085 2024-05-08
IoN
University College, London
Phase 2/3 Active not recruiting
NCT02938702 2022-04-25
Active Surveillance on Papillary Thyroid Microcarcinoma
Seoul National University Hospital
Active not recruiting